1. Lax Uterosacral Ligament and Urge Urinary Incontinence: MRI Findings in Symptomatic Patients Versus Healthy Volunteers
    Rania F. El-Sayed et al, 2024, International Urogynecology Journal CrossRef
  2. Acupuncture for Women with Overactive Bladder: Perspective of Traditional Chinese Medicine and Related Mechanism
    Hao Wang et al, 2023, International Journal of General Medicine CrossRef
  3. The Investigation of Percutaneous Tibial Nerve Stimulation (PTNS) as a Minimally Invasive, Non-Surgical, Non-Hormonal Treatment for Overactive Bladder Symptoms
    Connor McPhail et al, 2023, Journal of Clinical Medicine CrossRef
  4. Therapeutic targets in the brain for overactive bladder: A focus on angiotensin II type 1 receptor
    Shogo Shimizu, 2023, Journal of Pharmacological Sciences CrossRef
  5. Vibegron shows high selectivity and potent agonist activity for β3-adrenoceptors, irrespective of receptor density
    Shota Yamamoto et al, 2023, PLOS ONE CrossRef
  6. Genetic Variation in CYP2D6, UGT1A4, SLC6A2 and SLCO1B1 Alters the Pharmacokinetics and Safety of Mirabegron
    Paula Soria-Chacartegui et al, 2024, Pharmaceutics CrossRef
  7. Ultra-soft and highly stretchable tissue-adhesive hydrogel based multifunctional implantable sensor for monitoring of overactive bladder
    Byungkook Oh et al, 2023, Biosensors and Bioelectronics CrossRef
  8. Physical activity and risk factors in subjects with overactive bladder
    Aneta Dąbek, 2022, Fizjoterapia Polska CrossRef
  9. Evaluation of Food Effect on the Pharmacokinetics of Velufenacin, a New Muscarinic Receptor Antagonist, in Healthy Subjects
    Juyoung Khwarg et al, 2024, Clinical Pharmacology in Drug Development CrossRef
  10. Effect of mirabegron on lipid profile (serum cholesterol and triglyceride) in Iraqi patients with overactive bladder
    Hiba Hameed et al, 2024, F1000Research CrossRef
  11. Efficacy and safety of vaginal electrical stimulation as an alternative or adjunct treatment for overactive bladder syndrome in women: a meta-analysis of randomized controlled trials
    Jiapeng Huang et al, 2023, International Urogynecology Journal CrossRef
  12. Multi-omic analysis revealed the therapeutic mechanisms of Alpinia oxyphylla fructus water extract against bladder overactivity in spontaneously hypertensive rats
    Yan Tie et al, 2024, Phytomedicine CrossRef
  13. Mouse Bladder Smooth Muscle Lack the Functional Active NMDAR
    Zhean Zhan et al, 2024, Neurourology and Urodynamics CrossRef
  14. Drug therapy targeting angiotensin II type 1 receptors in brain against frequent urination
    Shogo Shimizu, 2023, Folia Pharmacologica Japonica CrossRef
  15. Preliminary evidence for therapeutic impact of intravesical glucosamine on protamine sulfate and potassium chloride-induced bladder overactivity in rat model
    Shing-Hwa Lu et al, 2024, World Journal of Urology CrossRef
  16. Urinary Symptoms in Older Adults with Chronic Kidney Disease
    Emily Janak et al, 2024, Kidney Disease in the Elderly CrossRef
  17. The emerging role of the urinary microbiome in benign noninfectious urological conditions: an up-to-date systematic review
    Maria Camila Suarez Arbelaez et al, 2023, World Journal of Urology CrossRef
  18. Drugs Currently Undergoing Preclinical or Clinical Trials for the Treatment of Overactive Bladder: A Review
    Silvia Joseph et al, 2022, Current Therapeutic Research CrossRef
  19. Acupuncture at Weizhong (BL40) attenuates acetic acid-induced overactive bladder in rats by regulating brain neural activity through the modulation of mast cells and tibial nerves
    Xin Liu et al, 2024, Journal of Integrative Medicine CrossRef